Talk Precision Medicine
Florence Raynaud discusses the team sport of drug discovery in academia. She takes us through the complexity of finding suitable small molecule candidates for in vivo testing.
18 / 04 / 2022 | Florence Raynaud
Florence Raynaud understands that small molecule drug discovery in an academic setting is all about teamwork. She uses ADME screening methods, driven by LC-MS, to understand and predict how compounds will be absorbed, distributed and metabolized. She focuses on finding the right compounds to move forward for in vivo testing, and she shows examples of some preclinical models that were validated in the clinical environment.
“You need good pharmaceutical properties, and you need properties that you’re going to be able to translate to man. And this is where my job starts.”
